The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the U.K.
Open accessAbstract
OBJECTIVE: To assess, in the general diabetic population, 1) the prevalence of painful neuropathic symptoms; 2) the relationship between symptoms and clinical severity of neuropathy; and 3) the role of diabetes type, sex, and ethnicity in painful neuropathy. RESEARCH DESIGN AND METHODS: Observational study of a large cohort of diabetic patients receiving community-based health care in northwest England (n = 15,692). Painful diabetic neuropathy (PDN) was assessed using neuropathy symptom score (NSS) and neuropathy disability score (NDS). RESULTS: Prevalence of painful symptoms (NSS ≥5) and PDN (NSS ≥5 and NDS ≥3) was 34 and 21%, respectively. Painful symptoms occurred in 26% of patients without neuropathy (NDS ≤2) and 60% of patients with severe neuropathy (NDS >8). Adjusted risk of painful neuropathic symptoms in type 2 diabetes was double that of type 1 diabetes (odds ratio [OR] = 2.1 [95% CI 1.7–2.4], P < 0.001) and not affected by severity of neuropathy, insulin use, foot deformities, smoking, or alcohol. Women had 50% increased adjusted risk of painful symptoms compared with men (OR = 1.5 [1.4–1.6], P < 0.0001). Despite less neuropathy in South Asians (14%) than Europeans (22%) and African Caribbeans (21%) (P < 0.0001), painful symptoms were greater in South Asians (38 vs. 34 vs. 32%, P < 0.0001). South Asians without neuropathy maintained a 50% increased risk of painful neuropathy symptoms compared with other ethnic groups (P < 0.0001). CONCLUSIONS: One-third of all community-based diabetic patients have painful neuropathy symptoms, regardless of their neuropathic deficit. PDN was more prevalent in patients with type 2 diabetes, women, and people of South Asian origin. This highlights a significant morbidity due to painful neuropathy and identifies key groups who warrant screening for PDN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Diabetic peripheral polyneuropathy (also known as diabetic neuropathy) affects 50% of patients with diabetes [3–5]”
From A Consideration of the Psychological Aspects to Managing Patients with Painful Diabetic Neuropathy: An Insight into Pain Management Services at a Tertiary Centre in the UK (2021) · cites this paper as [4]
Experimental — accuracy not yet measuredIn the citing paper
“with previous studies suggesting that it affects 21% of patients with neuropathy (23)”
From Development of a Core Outcome Set for Studies Assessing Interventions for Diabetes-Related Foot Ulceration (2024) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global burden of diabetic foot disease
Boulton, A. J., Vileikyte, L., Ragnarson-Tennvall, G., & Apelqvist, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67698-2 · Cited by 2,566
Self-citationYoung, M. J., Boulton, A. J. M., Macleod, A. F., Williams, D. R. R., & Sonksen, P. H. (1993) · Diabetologia · doi:10.1007/bf00400697 · Cited by 1,502
Self-citationAbbott, C. A., Carrington, A. L., Ashe, H., Bath, S., Every, L. C., Griffiths, J., Hann, A. W., Hussein, A., Jackson, N., Johnson, K. E., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00698.x · Cited by 1,056
Self-citationThe Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes
Davies, M., Brophy, S., Williams, R., & Taylor, A. (2006) · Diabetes Care · doi:10.2337/dc05-2228 · Cited by 746
Tesfaye, S., Stevens, L. K., Stephenson, J. M., Fuller, J. H., Plater, M., Ionescu-Tirgoviste, C., Nuber, A., Pozza, G., & Ward, J. D. (1996) · Diabetologia · doi:10.1007/s001250050586 · Cited by 695
Bril, V., England, J., Franklin, G. M., Backonja, M., Cohen, J., Del Toro, D., Feldman, E., Iverson, D. J., Perkins, B., Russell, J. W., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182166ebe · Cited by 634
Daousi, C., MacFarlane, I. A., Woodward, A., Nurmikko, T. J., Bundred, P. E., & Benbow, S. J. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01271.x · Cited by 454
Foot complications in Type 2 diabetes: an Australian population‐based study
Tapp, R. J., Shaw, J. E., De Courten, M. P., Dunstan, D. W., Welborn, T. A., & Zimmet, P. Z. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00881.x · Cited by 193
Cabezas-Cerrato, J. (1998) · Diabetologia · doi:10.1007/s001250051063 · Cited by 192
Abbott, C. A., Garrow, A. P., Carrington, A. L., Morris, J., Van Ross, E. R., & Boulton, A. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.1869 · Cited by 171
Self-citation
Cited by
Items 301–400 of 870
Gerber, S., & Saeed, N. (2021) · British Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.bjoms.2021.11.010 · Cited by 24
Liao, J., Kang, A., Xia, C., Young, T. K., Tanna, G. L. D., Arnott, C. G., Pollock, C. A., Krishnan, A. V., Agarwal, R., Bakris, G. L., et al. (2022) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101331 · Cited by 25
Tavakoli, M., Mitu-Pretorian, M., Petropoulos, I. N., Fadavi, H., Asghar, O., Alam, U., Ponirakis, G., Jeziorska, M., Marshall, A., Efron, N., et al. (2012) · Diabetes · doi:10.2337/db12-0574 · Cited by 247
Self-citationThe Characteristics of Diabetic Residents in European Nursing Homes: Results from the SHELTER Study
Szczerbińska, K. E., Topinková, E., Brzyski, P., van der Roest, H. G., Richter, T., Finne‐Soveri, H., Denkinger, M. D., Gindin, J., Onder, G., & Bernabei, R. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.11.009 · Cited by 24
Müller-Stich, B. P., Billeter, A. T., Fleming, T. H., Fischer, L., Büchler, M. W., & Nawroth, P. P. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.12.007 · Cited by 25
Yang, L., Li, Q., Liu, X., & Liu, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091479 · Cited by 33
Spinal Inhibitory Dysfunction in Patients With Painful or Painless Diabetic Neuropathy
Worthington, A., Kalteniece, A., Ferdousi, M., D’Onofrio, L., Dhage, S. S., Azmi, S., Adamson, C., Hamdy, S., Malik, R. A., Calcutt, N. A., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2797 · Cited by 26
Self-citationMaheshwary, N., Saeed, T., Nasrullah, M., et al. (2014) · International Journal of General Medicine · doi:10.2147/ijgm.s64419 · Cited by 24
Living with painful diabetic neuropathy: insights from focus groups into fears and coping strategies
Kanera, I. M., van Laake‐Geelen, C. C. M., Ruijgrok, J. M., Goossens, M. E. J. B., de Jong, J. R., Verbunt, J., Geerts, M., Smeets, R., & Kindermans, H. P. J. (2018) · Psychology and Health · doi:10.1080/08870446.2018.1518526 · Cited by 27
Prevalence of common causes of neuropathic pain in Korea: population-based observational study
Bang, S., Kim, Y. S., Lee, S. Y., Park, U., Kim, T.-K., & Choi, Y. N. (2019) · Journal of International Medical Research · doi:10.1177/0300060519888102 · Cited by 24
“Several studies have reported on the prevalence of neuropathy in a diabetic population.(23,24) However, there are few reports of the prevalence of DN in the general population.”
BackgroundKarlsson, P., Gylfadottir, S. S., Kristensen, A. G., Ramirez, J. D., Cruz, P. F., Le, N., SHILLO, P. R., Tesfaye, S. H., Rice, A. S. C., Tankişi, H., et al. (2021) · Diabetologia · doi:10.1007/s00125-020-05352-9 · Cited by 25
Fisher, A. S., Lanigan, M. T., Upton, N., & Lione, L. A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.614990 · Cited by 32
Croosu, S. S., Hansen, T. M., Røikjer, J., Mørch, C. D., Ejskjær, N., & Frøkjær, J. B. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1835-1877 · Cited by 25
Wang, S., Xia, C., Zheng, Q., Wang, A., & Tan, Q. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s383960 · Cited by 25
Diabetic neuropathy: Past, present, and future.
Aldave, J. E. Q., Durand‐Vásquez, M. D. C., Osorio, E. R. G., Suárez-Rojas, J., Roseboom, P. J., Alcalá‐Mendoza, R. M., Arroyo, J., Zavaleta‐Gutiérrez, F. E., Urteaga, L. A. C., & Concepción‐Zavaleta, M. J. (2023) · PubMed Central · doi:10.22088/cjim.14.2.153 · Cited by 47
Jane, S., Lin, M., Chiu, W., Beaton, R. D., & Chen, M. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011897 · Cited by 24
NerveCheck for the Detection of Sensory Loss and Neuropathic Pain in Diabetes
Ponirakis, G., Odriozola, M. N., Odriozola, S., Petropoulos, I. N., Azmi, S., Ferdousi, M., Fadavi, H., Alam, U., Marshall, A. G., Jeziorska, M., et al. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0279 · Cited by 26
Self-citationCost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review
Ruiz‐Negrón, N., Menon, J., King, J. B., Ma, J., & Bellows, B. K. (2019) · PharmacoEconomics · doi:10.1007/s40273-018-00761-6 · Cited by 26
Small fiber neuropathy in Sjögren syndrome: Comparison with other small fiber neuropathies
Descamps, E., Henry, J., Labeyrie, C., et al. (2020) · Muscle & Nerve · doi:10.1002/mus.26824 · Cited by 22
Disease related changes in vocal parameters of patients with type 2 diabetes mellitus
Gölaç, H., Atalık, G., Türkcan, A. K., & Yılmaz, M. (2021) · Logopedics Phoniatrics Vocology · doi:10.1080/14015439.2021.1917653 · Cited by 26
Araya, E. I., Nones, C. F. M., Ferreira, L. E. N., Kopruszinski, C. M., da Cunha, J. M., & Chichorro, J. G. (2017) · Brain Research · doi:10.1016/j.brainres.2017.06.004 · Cited by 22
Ghandour, R., Mikki, N., Rmeileh, N. M. A., Jerdén, L., Norberg, M., Eriksson, J. W., & Husseini, A. S. (2018) · Primary care diabetes · doi:10.1016/j.pcd.2018.07.002 · Cited by 26
Koetsier, E., Franken, G., Debets, J., et al. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13065 · Cited by 22
MicroRNA-193a Downregulates HMGB1 to Alleviate Diabetic Neuropathic Pain in a Mouse Model
Wu, B., Guo, Y., Chen, Q., Xiong, Q., & Min, S. (2019) · NeuroImmunoModulation · doi:10.1159/000503325 · Cited by 22
Selvy, M., Cuménal, M., Kerckhove, N., Courteix, C., Busserolles, J., & Balayssac, D. (2020) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2020.1764934 · Cited by 27
“However, the prevalence of neuropathic pain increased to 60% in those with severe clinical neuropathy [9].”
BackgroundRøikjer, J., Wegeberg, A., Nikontovic, A., Brock, C., & Vestergaard, P. (2024) · Primary care diabetes · doi:10.1016/j.pcd.2024.08.006 · Cited by 27
Cardinez, N., Lovblom, L. E., Orszag, A., Bril, V., Cherney, D. Z. I., & Perkins, B. A. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.06.002 · Cited by 20
Lima, R. A. D. O., Piemonte, G. A., Nogueira, C. R., & Nogueira, V. D. S. N. (2021) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000337 · Cited by 26
“Many trials have evaluated the efficacy of exercise programs to prevent falls in older patients, and the Prevention of Falls Network Europe developed a taxonomy that classifies exercise modality as follows: (1) gait, balance, and functional training; (2) strength/ resistance training; (3) flexibility; (4) three-dimens…”
BackgroundZhang, Y., Zhang, S., Pan, L., Wang, B., Sun, Y., Gao, L., Wang, L., Cui, L., Zhang, Q., Heng, S., et al. (2021) · Pain and Therapy · doi:10.1007/s40122-021-00281-w · Cited by 22
Peripheral Neuropathies Derived from COVID-19: New Perspectives for Treatment
Córdova, A., Caballero-García, A., Pérez-Valdecantos, D., Roche, E., & Noriega, D. C. (2022) · Biomedicines · doi:10.3390/biomedicines10051051 · Cited by 24
“have observed that one-third of diabetics had painful neuropathic symptoms [12] with an 11% prevalence of PN in diabetic patients [13].”
BackgroundAllwright, M., Karrasch, J. F., O'Brien, J. A., Guennewig, B., & Austin, P. J. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110725 · Cited by 26
Elafros, M. A., & Callaghan, B. C. (2023) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001291 · Cited by 31
Almurdhi, M. M., Reeves, N. D., Bowling, F. L., Boulton, A. J. M., Jeziorska, M., & Malik, R. A. (2016) · Diabetic Medicine · doi:10.1111/dme.13163 · Cited by 24
Self-citationFrequent pain in older people with and without diabetes – Finnish community based study
Karjalainen, M., Saltevo, J. T., Tiihonen, M., Haanpää, M. L., Kautiainen, H., & Mäntyselkä, P. T. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0762-y · Cited by 25
“ful neuropathy symptoms was estimated to be as high as 34% [11].”
BackgroundLin, J., He, Y., Zhu, N., & Peng, B. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2642-4 · Cited by 22
Weng, Y., Tsai, S., Lyu, R., Chu, C., Ro, L., Liao, M., Chang, H., Chen, C., Hwang, J., & Kuo, H. (2020) · Journal of Diabetes Research · doi:10.1155/2020/6356459 · Cited by 22
Painful Diabetic Neuropathy: Many Similarly Effective Therapies With Widely Dissimilar Costs
Callaghan, B. C., & Feldman, E. L. (2014) · Annals of Internal Medicine · doi:10.7326/m14-2157 · Cited by 21
McCormick, K. G., Scorletti, E., Bhatia, L. S., Calder, P. C., Griffin, M. J., Clough, G. F., & Byrne, C. D. (2015) · Diabetologia · doi:10.1007/s00125-015-3628-2 · Cited by 20
Brown, S. T., Nixon, J., Ransom, M., Gilberts, R. M., Dewhirst, N., McGinnis, E., Longo, R., Game, F. L., Bojke, C., Chadwick, P., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035947 · Cited by 21
Akintoye, O. O., Owoyele, B. V., Fabunmi, O. A., Raimi, T. H., Oniyide, A. A., Akintoye, A. O., Ajibare, A. J., Ajayi, D. D., & Adeleye, G. S. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04377 · Cited by 21
“Diabetic painful neuropathy (DNP) is the commonest and most worrisome presentation of diabetic polyneuropathy (Abbott et al., 2011), which is defined by the International Association for the Study of Pain (IASP) as pain arising as a direct consequence of abnormalities in the somatosensory neural system of known diabet…”
BackgroundDubey, V. N., Dave, J. M., Beavis, J., & Coppini, D. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820965583 · Cited by 20
Spinal Cord Stimulation for Painful Diabetic Neuropathy
Yeung, A. M., Huang, J. K., Nguyen, K. T., Xu, N. Y., Hughes, L. T., Agrawal, B. K., Ejskjær, N., & Klonoff, D. C. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221133795 · Cited by 40
Qu, S., Wang, H.-Z., Hu, Q., Ma, Y.-Q., Kang, Y., Ma, L., Li, X., Chen, L., Liu, B., Shao, X., et al. (2023) · Purinergic Signalling · doi:10.1007/s11302-023-09972-9 · Cited by 23
“One-third of diabetic patients suffer from painful neuropathic symptoms, including par-esthesia, hyperalgesia, and allodynia [2], which have a tremendous impact on their daily lives, sleep, and mental health.”
Diagnosing and managing diabetic somatic and autonomic neuropathy
Azmi, S., Ferdousi, M., Kalteniece, A., Almuhannadi, H., Al‐Mohamedi, A., Hadid, N. H., Mahmoud, S., Bhat, H., Gad, H., Khan, A., et al. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819826890 · Cited by 23
Self-citationYokoyama, H., Tsuji, T., Hayashi, S., Kabata, D., & Shintani, A. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13117 · Cited by 21
Murine model and mechanisms of treatment-induced painful diabetic neuropathy
Nicodemus, J. M., Enriquez, C., Marquez, A. M., Anaya, C. J., & Jolivalt, C. G. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.04.036 · Cited by 22
“In both forms, neuropathy is the most common complication of long-term diabetes and approximately 30% of such subjects develop chronic neuropathic pain (Abbott et al., 2011).”
BackgroundRozen, S. M., Wolfe, G. I., Vernino, S. A., Raskin, P., Hynan, L. S., Wyne, K. L., Fulmer, R., Pandian, G., Sharma, S. K., Mohanty, A. J., et al. (2024) · Annals of Surgery · doi:10.1097/sla.0000000000006228 · Cited by 19
Jia, S., Yin, W.-Q., Xu, W., Li, J., Yan, W., & Lin, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1436146 · Cited by 22
Treatment of painful polyneuropathies of diabetic and other origins with 10 kHz SCS: a case series
Sills, S. M. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1732065 · Cited by 19
Croosu, S. S., Hansen, T. M., Brock, B., Drewes, A. M., Brock, C., & Frøkjær, J. B. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147882 · Cited by 22
“(Schreiber, 2015; Juster-Switlyk and Smith, 2016) Up to 50% of all individuals with diabetes develop various degrees of DPN, and approximately 16–26% develop painful DPN, also referred to as neuropathic pain.(Abbott et al., 2011).”
BackgroundPeripheral Ion Channel Gene Screening in Painful- and Painless-Diabetic Neuropathy
Ślęczkowska, M., Almomani, R., Marchi, M., de Greef, B. T. A., Sopacua, M., Hoeijmakers, J. G. J., Lindsey, P. J., Salvi, E., Bönhof, G. J., Ziegler, D., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137190 · Cited by 20
Self-citationPRDX6: A protein bridging S-palmitoylation and diabetic neuropathy
Cao, Y. W., Wang, W., Zhan, X., & Zhang, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.992875 · Cited by 21
“Diabetic peripheral neuropathy (DPN), is characterized by mechanical allodynia, spontaneous pain, and paresthesia (tingling, shooting, or electric shock sensations), affecting 25 to 30% of patients with diabetes over the course of the disease (1, 2).”
BackgroundArtificial Intelligence in Efficient Diabetes Care
Khodve, G., & Banerjee, S. (2022) · Current Diabetes Reviews · doi:10.2174/1573399819666220905163940 · Cited by 20
Neuropathic Pain With and Without Diabetic Peripheral Neuropathy in Type 1 Diabetes
Braffett, B. H., ghormli, L. K. E., Albers, J. W., Feldman, E. L., Herman, W. H., Gubitosi‐Klug, R., Martin, C. L., Orchard, T. J., White, N. H., Lachin, J. M., et al. (2024) · Diabetes Care · doi:10.2337/dc23-1749 · Cited by 23
Gálvez, R., Mayoral, V., Cebrecos, J., Medel, J., Morte, A., Sust, M., Vaqué, A., Montes, A., Reina, F. N., Martínez, L. C., et al. (2024) · European Journal of Pain · doi:10.1002/ejp.4755 · Cited by 20
“Prevalence of painful diabetic neuropathy (PDN) among patients with diabetes ranges from 8% to 35%, and PDN impacts quality of life (Abbott et al., 2011; Gylfadottir et al., 2020; Risson et al., 2017; Staehelin, 2023; Syed et al., 2023; Ziegler et al., 2022).”
Ankle-brachial index and diabetic neuropathy: study of 225 patients
Chevtchouk, L., da Silva, M. H. S., & Nascimento, O. J. M. (2017) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20170084 · Cited by 21
Battula, P., Afreen, S., Meena, E., et al. (2017) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20173984 · Cited by 19
Costa, Y. M., Karlsson, P., Bonjardim, L. R., Conti, P. C. R., Tankişi, H., Jensen, T. S., Nyengaard, J. R., Svensson, P. J., & Baad‐Hansen, L. (2019) · Scientific Reports · doi:10.1038/s41598-018-37041-4 · Cited by 20
Redivo, D. D. B., Jesus, C. H. A., Sotomaior, B. B., Gasparin, A. T., & da Cunha, J. M. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.111992 · Cited by 19
Mehta, K., Behl, T., Kumar, A., Uddin, M. S., Zengin, G., & Arora, S. (2020) · Current Protein and Peptide Science · doi:10.2174/1389203721999201208195901 · Cited by 21
Petropoulos, I. N., Javed, S., Azmi, S., Khan, A., Ponirakis, G., & Malik, R. A. (2016) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2016.06.002 · Cited by 22
Self-citationDiabetische Neuropathie und diabetischer Fuß (Update 2019)
Lechleitner, M., Abrahamian, H., Francesconi, C., Kofler, M., Sturm, W., & Köhler, G. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-1487-4 · Cited by 18
Pain-related evoked potentials in patients with large, mixed, and small fiber neuropathy
Siedler, G., Sommer, C., & Üçeyler, N. (2019) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.12.006 · Cited by 19
Painful Diabetic Neuropathy: The Need for New Approaches
Yeung, A. M., Huang, J. K., Nguyen, K. T., Xu, N. Y., Hughes, L. T., Agrawal, B. K., Ejskjær, N., & Klonoff, D. C. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221132252 · Cited by 23
Neuropathic Pain in the Emergency Setting: Diagnosis and Management
Doneddu, P. E., Pensato, U., Iorfida, A., Alberti, C., Nobile‐Orazio, E., Fabbri, A., & Voza, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12186028 · Cited by 26
The role of micro-RNAs in neuropathic pain—a scoping review
Sampath, K. K., Belcher, S., Hales, J., Thomson, O. P., Farrell, G., Gisselman, A. S., Katare, R., & Tumilty, S. (2023) · PAIN Reports · doi:10.1097/pr9.0000000000001108 · Cited by 19
“1 Therefore, future studies may explore whether miRNAs involved in DN are also involved in painful DN.”
BackgroundFerhatović, L., Banožić, A., Kostić, S., Sapunar, D., & Puljak, L. (2012) · Acta Histochemica · doi:10.1016/j.acthis.2012.11.006 · Cited by 19
An overview of painful diabetic peripheral neuropathy: Diagnosis and treatment advancements
Hagedorn, J. M., Engle, A. M., George, T. K., Karri, J. V., Abdullah, N. M., Ovrom, E. A., Bocanegra‐Becerra, J. E., & D'Souza, R. S. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109928 · Cited by 23
Juhn, M. S., Parsons, B., Varvara, R., & Sadosky, A. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1030375 · Cited by 18
Pruitt, J., III, Moracho-Vilrriales, C., Threatt, T. B., Wagner, S., Wu, J., & Romero-Sandoval, E. A. (2017) · Journal of Pain Research · doi:10.2147/jpr.s129139 · Cited by 18
“These data contradict previous literature in which more women reported symptoms of p-DN.(28) Whether these differences are due to the geographical locations of the studies (UK vs.”
Location and temporal memory of objects declines in aged marmosets (Callithrix jacchus)
De Castro, V., & Girard, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-88357-7 · Cited by 17
Matesanz-García, L., Schmid, A. B., Cáceres-Pajuelo, J. E., Cuenca‐Martínez, F., Arribas‐Romano, A., González‐Zamorano, Y., Goicoechea, C., & Fernández‐Carnero, J. (2022) · Journal of Pain · doi:10.1016/j.jpain.2022.06.007 · Cited by 22
Tesfaye, S. H., SLOAN, G. P., Petrie, J., White, D. A., Bradburn, M. J., Young, T. A., Rajbhandari, S. M., Sharma, S., Rayman, G. A., Gouni, R., et al. (2022) · Health Technology Assessment · doi:10.3310/rxuo6757 · Cited by 23
Ghoweba, R. E., Khowailed, A. A., Aboulhoda, B. E., Rashed, L. A., & Selmy, A. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102014 · Cited by 17
The Epidemiology of Diabetic Neuropathy
Hansen, C. S., Määttä, L. L., Andersen, S. T., & Charles, M. H. (2023) · Contemporary Diabetes · doi:10.1007/978-3-031-15613-7_2 · Cited by 17
Moon, H. I., Shin, J., Kim, Y. W., Chang, J. S., & Yoon, S. Y. (2020) · Muscle & Nerve · doi:10.1002/mus.26901 · Cited by 17
“Chi-squared testing was used to compare the distribution of baseline demographic characteristics and comorbidities between patients with and without DPN. Cox proportional hazard regression analyses were performed to identify hazards associated with CTS using hazard ratios and 95% confidence intervals (CIs).”
BackgroundInfluentialMechanisms of small nerve fiber pathology
Gross, F., & Üçeyler, N. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135316 · Cited by 21
Qian, Y., Zeng, Y., Lin, Q., Huang, H., Zhang, W., Yu, H., & Deng, B. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13535 · Cited by 19
Az oxidatív stressz szerepe a diabeteses neuropathia kialakulásában
Sztanek, F., Molnár, Á. M., & Balogh, Z. (2016) · Orvosi Hetilap · doi:10.1556/650.2016.30609 · Cited by 22
Franken, G., Debets, J., & Joosten, E. A. J. (2019) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.13070 · Cited by 18
Pain Management in People with Diabetes-Related Chronic Limb-Threatening Ischemia
Jiang, X., Yuan, Y. C., Ma, Y., Zhong, M., Du, C., Boey, J., Armstrong, D. G., Deng, W., & Duan, X. (2021) · Journal of Diabetes Research · doi:10.1155/2021/6699292 · Cited by 22
“Diabetic neuropathy is a unique neurodegenerative disorder of the peripheral nervous system, of which approximately 30-50% of patients developed neuropathic pain [30].”
BackgroundElectrodiagnostic studies and new diagnostic modalities for evaluation of peripheral nerve disorders
Hannaford, A. P., Paling, E., Silsby, M., Vincenten, S. C. C., van Alfen, N., & Simon, N. G. (2024) · Muscle & Nerve · doi:10.1002/mus.28068 · Cited by 18
Liao, Q., Yang, Y., Li, Y., Zhang, J., Fan, K., Guo, Y., Chen, J., Chen, Y., Zhu, P., Huang, L., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01723-6 · Cited by 21
“Diabetic neuropathy has been reported to affect more than half of diabetic patients [3], with approximately 30% progressing to PDN [4], manifesting as allo-dynia, hyperalgesia, and spontaneous pain.”
BackgroundLong-Term Outcomes in the Management of Painful Diabetic Neuropathy
Mai, L. M., Clark, A. J., GORDON, A. S., Lynch, M. E., Morley-Forster, P. K., Nathan, H., Smyth, C. E., Stitt, L., Toth, C. C., Ware, M. A., et al. (2017) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2016.429 · Cited by 15
“In those with severe diabetic neuropathy, the prevalence of painful symptoms is as high as 60%.(1) Painful diabetic neuropathy (PDN), described as a burning, stabbing, pricking, or aching sensation, primarily affects the toes, feet, and legs in a distal, symmetric pattern,(4,5) and often interferes with mobility, slee…”
BackgroundPrediction of protective sensory loss, neuropathy and foot ulceration in type 2 diabetes
Paisey, R., Darby, T., George, A. M., Waterson, M., Hewson, P., Paisey, C., & Thomson, M. P. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000163 · Cited by 16
on behalf of the OPTION-DM group, Selvarajah, D., Petrie, J., White, D. A., Julious, S. A., Bortolami, O., Cooper, C. L., Bradburn, M. J., Loban, A., Bowler, H., et al. (2018) · Trials · doi:10.1186/s13063-018-2959-y · Cited by 16
Rhudy, J. L., Huber, F. A., Toledo, T. A., Kell, P. A., Street, E. N., & Shadlow, J. O. (2021) · Pain · doi:10.1097/j.pain.0000000000002458 · Cited by 17
Vissers, P. A. J., Mols, F., Thong, M. S. Y., et al. (2015) · Journal of Cancer Survivorship · doi:10.1007/s11764-015-0429-z · Cited by 16
A standardized clinical evaluation of phenotypic diversity in diabetic polyneuropathy
Scholz, J., Rathmell, J. P., David, W. S., Chad, D. A., Broderick, A., Perros, S., Shin, N. S., Wells, J. L., Davis, J. B., DiMaggio, C. J., et al. (2016) · Pain · doi:10.1097/j.pain.0000000000000648 · Cited by 18
Didangelos, T., & Veves, A. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161117666190521101342 · Cited by 17
Clinical Features and Rules of Chinese Herbal Medicine in Diabetic Peripheral Neuropathy Patients
Zhao, J., Li, Y., Xin, L., Sun, M., Yu, C., Shi, G., Bao, T., Liu, J., Ni, Y., Lu, R., et al. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/5795264 · Cited by 17
“We found that symptoms due to DPN had a frequency of 75%, which was higher than the findings reported in previous studies, which ranged from 16% to 65% [26, 27].”
ResultMedium-term outcomes of multi-disciplinary surgical management of non-ischemic diabetic heel ulcers
Phyo, N., Tang, W., & Kavarthapu, V. (2021) · Journal of Clinical Orthopaedics and Trauma · doi:10.1016/j.jcot.2021.01.012 · Cited by 16
“(3) The presence of osteomyelitis in the calcaneum (Fig.”
BackgroundTwiddy, H., Frank, B., & Alam, U. (2021) · Diabetes Therapy · doi:10.1007/s13300-020-00983-y · Cited by 15
Salem, E. A., Alqahtani, S. M., El‐Shoura, E. A. M., Zaghlool, S. S., Abdelzaher, L. A., Mohamed, S. A. M., Alalhareth, I. S., & Sheref, A. A. M. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-03920-7 · Cited by 18
“Nearly 50% of diabetic individuals have diabetic neuropathy (Abbott et al. 2011; Selvarajah et al. 2011) probably due to deficiency of insulin action in the brain besides damage induced by persistent hyperglycemia (Brands et al. 2004).”
Tantigegn, S., Ewunetie, A. A., Assemie, M. A., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284568 · Cited by 15
Placebo and nocebo responses in painful diabetic neuropathy: systematic review and meta-analysis
Frisaldi, E., Vollert, J., Sultani, H. A., Benedetti, F., & Shaibani, A. I. (2023) · Pain · doi:10.1097/j.pain.0000000000003000 · Cited by 15
Bouhassira, D., Tesfaye, S. H., Sarkar, A., Soisalon‐Soininen, S., Stemper, B., & Baron, R. (2023) · Pain · doi:10.1097/j.pain.0000000000003085 · Cited by 17
Negussie, Y. M., & Bekele, N. T. (2024) · Scientific Reports · doi:10.1038/s41598-024-53951-y · Cited by 19
Drugs for the treatment of peripheral neuropathies
Marmiroli, P., & Cavaletti, G. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1120719 · Cited by 15
“betes, women and non-Caucasian persons.[52,53] The pathogenesis of the different types of diabetic neuropathy is probably different, with compelling evidence of”
BackgroundIsobolographic Analyses of Proglumide–Celecoxib Interaction in Rats with Painful Diabetic Neuropathy
Suárez-Méndez, S., Tovilla‐Zárate, C. A., Ortega‐Varela, L. F., Bermudez‐Ocaña, D. Y., Blé‐Castillo, J. L., González‐Castro, T. B., Zetina‐Esquivel, A. M., Díaz-Zagoya, J. C., & Juárez‐Rojop, I. E. (2017) · Drug Development Research · doi:10.1002/ddr.21382 · Cited by 15
Metadata
- Authors
- Abbott, C. A., Malik, R. A., van Ross, E. R. E., Kulkarni, J., & Boulton, A. J. M.
- Affiliations
- University of Manchester (GB)
- Disablement Services Centre, Withington Hospital, Manchester, U.K.
- Withington Community Hospital (GB)
- Corresponding author
- Abbott, Caroline A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-09-15
- Volume
- 34
- Issue
- 10
- Pages
- 2220-2224
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3177727
- OpenAlex
- W2162902338
- Semantic Scholar
- f503e4898de5486de267534e888652f729e9319c
- Cited by
- 868
- References
- 19
- Citations by year
- 2026: 38 · 2025: 67 · 2024: 74 · 2023: 69 · 2022: 70 · 2021: 97 · 2020: 99 · 2019: 64 · 2018: 54 · 2017: 48 · 2016: 47 · 2015: 52 · 2014: 41 · 2013: 35 · 2012: 12
- FWCI
- 19.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- e-space (Manchester Metropolitan University) (acceptedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- American Diabetes Association
- National Institute for Health and Care Research
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Keywords
- diabetic neuropathic pain, prevalence, type 2 diabetes, type 1 diabetes, sex differences, ethnicity, South Asians, neuropathy severity, neuropathic pain, neuropathy screening
- MeSH terms
- Administration, Oral, Adult, Aged, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Female, United Kingdom, Humans, Hypoglycemic Agents, Male, Middle Aged, Sex Factors, Age Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
